By expenditures
| Name | Title | Type |
|---|---|---|
| Jenny Englerth | CEO | Auditee |
| Gil Bernhard | Partner | Auditee |
| Brent Doores | Vice President of Finance | Auditee |
| Karen Harris | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 334060 | 2024 | 2024-12-20 | Cohnreznick LLP | $5.50M |
| 15598 | 2022 | 2024-02-05 | Cohnreznick LLP | $8.31M |
| 12740 | 2023 | 2024-01-22 | Cohnreznick LLP | $8.80M |
| 25106 | 2022 | 2022-12-22 | Cohnreznick LLP | $7.60M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 15598 | 2022 | 2024-02-05 | 588213 | 2022-004 | Significant Deficiency | - | L |
| 15598 | 2022 | 2024-02-05 | 588212 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 588211 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 588210 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 588209 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 11771 | 2022-004 | Significant Deficiency | - | L |
| 15598 | 2022 | 2024-02-05 | 11770 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 11769 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 11768 | 2022-003 | Significant Deficiency | - | AB |
| 15598 | 2022 | 2024-02-05 | 11767 | 2022-003 | Significant Deficiency | - | AB |
| 12740 | 2023 | 2024-01-22 | 585732 | 2023-004 | Significant Deficiency | Yes | L |
| 12740 | 2023 | 2024-01-22 | 585731 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 585730 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 585729 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 585728 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 585727 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 9290 | 2023-004 | Significant Deficiency | Yes | L |
| 12740 | 2023 | 2024-01-22 | 9289 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 9288 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 9287 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 9286 | 2023-003 | Material Weakness | Yes | AB |
| 12740 | 2023 | 2024-01-22 | 9285 | 2023-003 | Material Weakness | Yes | AB |
| 25106 | 2022 | 2022-12-22 | 611993 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 611992 | 2022-004 | Significant Deficiency | - | L |
| 25106 | 2022 | 2022-12-22 | 611991 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 611990 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 611989 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 35551 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 35550 | 2022-004 | Significant Deficiency | - | L |
| 25106 | 2022 | 2022-12-22 | 35549 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 35548 | 2022-003 | Significant Deficiency | - | AB |
| 25106 | 2022 | 2022-12-22 | 35547 | 2022-003 | Significant Deficiency | - | AB |